Platelet factor-4 concentration in adult veno-arterial ECMO patients.
Michael A MazzeffiMadeline ClarkAlison GrazioliColleen DuganRaymond RectorHeidi DaltonRonson J MadathilJay MenakerDaniel HerrKenichi TanakaPublished in: Perfusion (2020)
Our data suggest that PF4 concentration is mildly elevated during VA ECMO compared to control plasma. Estimated PF4-heparin ratios were not optimal for HIT antibody formation. These data support epidemiologic studies where HIT incidence is low during VA ECMO.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- end stage renal disease
- respiratory failure
- electronic health record
- ejection fraction
- newly diagnosed
- chronic kidney disease
- big data
- peritoneal dialysis
- risk factors
- venous thromboembolism
- prognostic factors
- machine learning
- mechanical ventilation
- growth factor
- patient reported outcomes
- patient reported
- young adults